ATS 2019 Virtual Final Program

ATS 2019 • Dallas, TX 176 MONDAY • MAY 20 P1017 Cardiopulmonary Limitation to Exercise in Systemic Sclerosis: A Case-Controlled Study/ A. Rimouche, S. Caravita, A. Bondue, J.-L. Vachiery, Brussels, Belgium, p.A3671 BASIC • CLINICAL THEMATIC POSTER SESSION B57 CLINICAL STUDIES IN LUNG INFECTIONS: RISK FACTORS AND BIOMARKERS 9:15 a.m. - 4:15 p.m. KBHCCD Area H (Hall F, Level 2) Viewing: Posters will be on display for entire session. Discussion: 11:15-12:00: authors will be present for individual discussion 12:00-1:00: authors will be present for discussion with assigned facilitators. Facilitator : M.S. Niederman, MD, New York, NY P1031 Antibiotic Resistance, Outcome and Risk Factors for Mortality of Pneumonia Caused by Klebsiella Pneumoniae Among Diabetics: A Retrospective Study in China/ B. Liu, H. Yi, Y. Guo, M. Zhou, Shanghai, China, p.A3672 P1032 Bronchoscopic Features, Associations and Outcomes of Organizing Pneumonia Following Allogeneic Hematopoietic Stem Cell Transplantation/ J. Frey, K. Brownback, Kansas City, KS, p.A3673 P1033 A Novel Lung Ultrasound Training Program to Predict Severity of Acute Lower Respiratory Tract Infections in Sri Lanka/ S. Vanderburg, I. Kodikara, M. Sellathurai, C. Bodinayake, A. Nagahawatte, C. Woods, E.D. Riviello, L.G. Tillekeratne, Durham, NC, p.A3674 P1034 Metagenomic Sequencing of Respiratory Microbial Communities for Detection of Etiologic Pathogens of Pneumonia in Mechanically-Ventilated Adult Patients/ R. Nettles, L. Yang, B. Methe, S. Qin, J.S. Bednash, A. Fitch, J. Evankovich, W. Bain, D.G. Dunlap, F. Shah, S. Rapport, J. Lee, A.M. Morris, B.J. McVerry, J. O’Grady, G. Kitsios, Pittsburgh, PA, p.A3675 P1035 Follow Up Chest Radiograph in Community Acquired Pneumonia (CAP) - Are We Meeting the Standards?/ M.S. Zeb, J. Ibrahim, H. Hamze, A. Ali, M. Annabel, N. Ahmad, K.S. Srinivasan, H. Moudgil, E. Crawford, Telford, United Kingdom, p.A3676 P1036 Oral Microbiome Community Composition and Metabolism of Nitrate to Nitrite Are Driven by Individual Variation That Is Independent of Time/ C. Koch, V. Heinrich, R. Nettles, S. Qin, C. Sparacino-Watkins, K. Li, B. Methe, A. Fitch, A. Morris, Pittburgh, PA, p.A3677 P1037 Analysis for Distribution Range and Drug Resistance of Pathogenic Bacteria in Sputum of Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD) Inpatients in Changchun China/ T. Ma, Y. Hu, B. Yan, Changchun, China, p.A3678 P1038 Plasma Amino Acid in Patients with Bacterial Pneumonia/ H. Ikeda, Yonezawa, Japan, p.A3679 Facilitator : E.M. Mortensen, MD, MSc, Farmington, CT P1039 Staphylococcus Spp. and Streptococcus Anginosus Group Play an Important Role in Pathogenesis of Lung Abscess and Pyothorax? - 16s Ribosomal RNA Gene Sequencing of Clinical Isolates from 29 Cases/ R. Katsuda, J. Inubushi, T. Eguchi, K. Terada, R. Kagami, S. Sasaki, T. Kawamura, Y. Nakahara, Himeji, Japan, p.A3680 P1040 Heterogeneity in Clinical Patterns of Lung Abscess in Developing Countries: Shifting of Old Paradigms and Emergence of New Evidence/ N. Bhatta, S. Pandey, M. Lamsal, A.R. Panta, R. Gurung, P. Koirala, D.R. Mishra, B. Bista, Dharan, Nepal, p.A3681 P1041 Bacterial Distribution and Antimicrobial Resistance Among Patients with Hyperglycemia or Diabetes in a Teaching Hospital in Shanghai/ H. Yi, M. Zhou, Shanghai, China, p.A3682 P1042 Multi-Drug Resistance Pathogens Trajectory in Patients with Hospital- Acquired and Ventilator-Associated Pneumonia: Where Are the End of Tunnel?/ A.S. Sadigov, R. Baylarov, A. Agayeva, B. Tagiyev, Baku, Azerbaijan, p.A3683 P1043 Risk Factors for Development of Pulmonary and Extra-Pulmonary Complications in Severe Community-Acquired Pneumonia/ A.S. Sadigov, S. Huseynova, F. Abdullayev, Baku, Azerbaijan, p.A3684 P1044 Survival with Optimal Medical Management in a Cohort of Severe Necrotizing Bacterial Lung Infection/ J.-C. Larose, H.T. Wang, K. Chagnon, G. Rakovich, Montreal, Canada, p.A3685 P1045 ESKAPE Pneumonia-No Escape. Extensive Drug Resistance, Severe Clinical Course and Higher Mortality in Cases of ESKAPE Positive Pneumonia/ S. Kumar, R.A. Jan, B.A. Fomda, P.A. Koul, Srinagar, India, p.A3686 P1046 Polymicrobial Pneumonia: More than the Sum of Its Parts/ L.J. Barkal, J. Yu, A. Henry, W. Wightman, A. Karim, D. Chen, D.J. Beebe, Stanford, CA, p.A3687 Facilitator : L.K. Sharma, PhD, New Haven, CT P1047 Validation of MRSA Specific Scoring Systems Among Hospitalized Patients with CAP/ N. Borsa, S. Aliberti, F. Blasi, M.I. Restrepo, Milano, Italy, p.A3688 P1048 Baseline Patient Characteristics Influence Sputum Testing for Patients Presenting with Severe COPD Exacerbations/ E. Sheehan, M. Kakol, N. Phillips, R. Vazquez Guillamet, C. Vazquez-Guillamet, Albuquerque, NM, p.A3689 P1049 The Effect of Thymol on Pseudomonas Aeruginosa Virulence Factors/ Z.E. Suntres, K.L. Kachur, Thunder Bay, Canada, p.A3690 P1050 Making It Mental - Neurological Manifestations of Legionnaires’ Disease/ D. Muscedere, S. Sahni, Y. Malyshev, G.K. Upadhya, R. Cofsky, New York, NY, p.A3691 P1051 Prognosis of Mortality in Bacterial Community Acquired Pneumonia (CAP) Using Metabolomics (fatty Acids and Lipids) as Potential Biomarkers/ B.W. Winston, M. Banoei, H.J. Vogel, A.M. Weljie, S. Tende, D.C. Angus, Calgary, Canada, p.A3692